Printer Friendly

INTUBATING CONDITIONS FOLLOWING RAPID SEQUENCE INDUCTION WITH THREE DOSES OF SUCCINYLCHOLINE.

BACKGROUND

Succinylcholine, a Neuromuscular Blocking Agent (NMBA) with the fastest onset and recovery time, [1] is considered the drug of choice for rapid sequence induction of anaesthesia. Traditionally, 1 mg/kg of succinylcholine is used for this purpose. The Effective Dose (ED) 95 of succinylcholine is less than 0.30 mg/kg. [2,3] Doses equivalent to twice the ED 95 are generally considered to be the appropriate dose of nondepolarising NMBAs for intubation. [4] A 0.8 mg/kg dose was equivalent to 3.5 - 4 times the ED 95. Recovery of spontaneous respiration following 0.8 mg/kg succinylcholine administration may not occur rapidly enough to prevent haemoglobin desaturation in patients whose ventilation is not assisted. [5,6] Based on a mathematical model of haemoglobin desaturation during apnoea, Benumof et al [7] predicted that in the large majority of patients with 1 mg/kg succinylcholine-induced apnoea, significant to life-threatening haemoglobin desaturation will occur when ventilation is not assisted. Heier et al[5] reported that significant haemoglobin desaturation (Sp[O.sub.2] < 80%) occurred in one-third of the volunteers during the period of apnoea induced by 1 mg/kg succinylcholine. Decreasing the dose of succinylcholine would allow a more rapid recovery of spontaneous ventilation, thereby proving a greater margin of safety in airway management. This study consists of a prospective, randomised, double-blind study to compare endotracheal intubating conditions and the apnoea duration after administration of 0.4, 0.6 and 0.8 mg/kg of succinylcholine in cases of rapid sequence induction of anaesthesia.

MATERIALS AND METHODS

The study was approved by the Hospital Ethics Committee and written informed consent was obtained from all patients. Sixty-nine American Society of Anesthesiologists (ASA) physical status I and II adult patients, aged 18-60 years, scheduled for elective surgery requiring general anaesthesia and tracheal intubation were included in this study. Patients with cardiac, pulmonary, neuromuscular disease, hepatic, renal impairment and those with body mass index > 28 kg/[m.sup.2] were excluded from the study, as were pregnant women. Patients with previous or family history of abnormal response to succinylcholine were also excluded. The airway was clinically assessed (mouth opening, Mallampati class, thyromental distance, range of neck movement, any obvious head or neck pathology) to exclude those in whom difficulty with intubation was anticipated. No premedication was administered.

In the operating room, standard monitoring was established [electrocardiogram (ECG), non-invasive blood pressure, pulse oximetry, capnography) and baseline (preinduction) measurements were recorded. Intravenous access was secured, and fentanyl 2 [micro]g/kg IV was administered. Patients were randomly allocated to one of the three groups (23 patients each) according to the dose of succinylcholine to be administered intravenously (0.4, 0.6 or 0.8 mg/kg) using a computer-generated random number table (sealed envelopes): Group 0.4 received 0.4 mg/kg of succinylcholine; Group 0.6 received 0.6 mg/kg of succinylcholine; and Group 0.8 received 0.8 mg/kg of succinylcholine. Succinylcholine was taken in a 2 mL syringe and saline 0.9% was added to make a volume of 2 mL. All drugs were prepared by an anaesthetist not involved with the study to keep the study investigator blinded. Pre-oxygenation using a tight-fitting mask was performed for 3 min with 100% oxygen. Anaesthesia was induced with propofol 2 mg/kg followed by application of cricoid pressure and administration of the designated dose of succinylcholine. Laryngoscopy was performed 50 s after the administration of succinylcholine (Size 3 Macintosh blade), aiming to intubate the trachea at 60 s. Cuffed tracheal tubes of 7 and 8 mm size were used in female and male patients, respectively. Tracheal intubation and grading of the intubating conditions was performed by an experienced anaesthetist unaware of the dose of succinylcholine given. The Cormack and Lehane [8] score of laryngoscopy was recorded: Grade 1= full view of epiglottis, Grade 2a= partial view of glottis, Grade 2b= only posterior extremity of glottis seen, Grade 3= only epiglottis seen, Grade 4= neither glottis nor epiglottis seen. Qualitative score system by Viby-Mogensen et al [9] employed for evaluation of intubating conditions. This include ease of laryngoscopy, position and movement of vocal cords, coughing and movement of the limbs [Table 1]. If jaw is relaxed (no resistance to laryngoscopic blade), it is considered as easy. If jaw is not fully relaxed (slight resistance to blade), it is considered as fair. If there is poor jaw relaxation (active resistance of patient to laryngoscopic blade), it is considered as difficult. Intubating conditions were considered as excellent (all variables were excellent), good (all variables were either excellent or good) or poor (the presence of a single variable listed under poor). Excellent or good intubating conditions considered as clinically acceptable; poor intubating conditions considered as clinically not acceptable. [9] Time taken to do the laryngoscopy has been noted. Blood pressure heart rate (HR) and Sp[O.sub.2] were recorded just before starting of anaesthesia (pre-induction), and after starting (post-induction) and then after every 1 min of tracheal intubation for 5 min (time 1 - 5). If bradycardia occurs while doing laryngoscopy (HR < 50 beats per min), atropine 0.6 mg was given. If there is decrease in mean arterial pressure (MAP) > 25%, ephedrine 6 mg was given in increments. Adverse events such as laryngospasm, bronchospasm, masseter spasm or muscle rigidity were recorded.

After tracheal intubation, ventilation (0.6% isoflurane and 66% nitrous oxide in oxygen using carbon dioxide absorption) was gently assisted manually to maintain an EtC[O.sub.2] between 35 and 40 mmHg. The patient's abdomen was continuously observed for respiratory movements. Apnoea time was defined as the time from IV succinylcholine administration to the time for first visible diaphragmatic contraction that coincided with reservoir bag movement. Time to resumption of spontaneous breathing was taken as the time from IV succinylcholine administration to the time for regular reservoir bag movements that produced a well-formed end-tidal C[O.sub.2] waveform. When the trachea could not be intubated because of inadequate relaxation, the lungs were ventilated by face mask and Rocuronium 0.6 mg/kg was administered IV and another attempt was made 1 min later. The study end-point was resumption of spontaneous breathing. Thereafter, anaesthesia was continued as appropriate for surgery.

Study Design

It is a prospective, randomised, double-blind, hospital-based controlled study.

Sample Size

It was calculated by taking the previous study results on rapid sequence intubation accepting a 2-tailed alpha error of 5% and a beta error of 20%. Power analysis was performed for apnoea time and time for resumption of regular spontaneous breathing. A sample of 23 patients were obtained in each group.

Patient Allocation

By a computer-generated random number, patients were randomly allocated to 3 groups.

Statistical Analysis

Descriptive statistics in the form of mean, standard deviation, frequency and percentages have been calculated for interval and categorical variables, respectively. To see a significant difference among the groups, One-Way Analysis of Variance (ANOVA) with post-hoc Bonferroni test has been applied to interval variables and Chi-square tests for categorical variables. P value= 0.05 (two-tailed) has been considered as the statistically significant level. Statistical Package for Social Sciences (SPSS) 18.0 statistical software has been used for the analysis.

RESULTS

Sixty-nine eligible patients were enrolled in the study, 23 in each group. Two patients in Group 0.4 mg/kg and three patients in Group 0.8 mg/kg were excluded from the study due to protocol violation. There were no significant differences in patient characteristics among the three groups [Table 2]. The modified Mallampati class of pharyngeal structures, Cormack grade of laryngoscopy and the duration of laryngoscopy in the three groups was comparable. Intubation was completed successfully in all (100%) patients. No patient required rocuronium administration. Excellent intubating conditions were obtained in 52.4%, 95.7% and 100% of the patients after 0.4, 0.6 and 0.8 mg/kg succinylcholine, respectively; P < 0.001. The 0.6 and 0.8 mg/kg groups were similar with regard to the incidence of excellent intubating conditions; P > 0.05. Overall intubating conditions were regarded as acceptable (excellent and good grade combined) in 66.7%, 100% and 100% of the patients after 0.4, 0.6 and 0.8 mg/kg succinylcholine, respectively. This difference was statistically significant (P < 0.001) [Table 3]. Comparable intubating conditions were achieved after 0.6 and 0.8 mg/kg succinylcholine; P > 0.05. Patients receiving 0.4 mg/kg succinylcholine had a frequent incidence (33.3%) of poor tracheal intubating conditions.

Laryngoscopy was easy in all patients, except one patient in Group 0.6 mg/kg succinylcholine. No patient had closed or closing vocal cords requiring administration of rocuronium before successful intubation. A greater number of patients (four of 21 patients) had sustained coughing in the group receiving 0.4 mg/kg succinylcholine compared with patients receiving 0.6 and 0.8 mg/kg succinylcholine, (P= 0.04). Five patients in Group 0.4 mg/kg succinylcholine had vigorous limb movement compared with none in the other two groups; P < 0.001 [Table 4].

Apnoea time and the time for regular spontaneous breathing (end-tidal C[O.sub.2] waveform) were dose-dependent and are presented in Table 5.

Haemodynamic responses to induction and intubation are shown in Tables 6 and 7. Pre-induction HR and MAP were comparable in three groups. There was no statistically significant difference in mean HR and MAP between the three groups at any time point.

Oxygen saturation before and following induction of anaesthesia and endotracheal intubation ranged between 97% and 100%. There were no episodes of bronchospasm, laryngospasm, masseter spasm or generalised rigidity observed.

DISCUSSION

This study demonstrates that satisfactory tracheal intubating conditions can be achieved in 1 min after succinylcholine administration with doses much less than the usually recommended dose of 0.8 mg/kg. The intubating conditions following 0.6 mg/kg succinylcholine were similar to those obtained after the 0.8 mg/kg dose. Doses of 0.4 mg/ kg did not often result in acceptable intubating conditions and therefore cannot be recommended for rapid sequence tracheal intubation.

The effectiveness of small doses of succinylcholine in achieving satisfactory intubating conditions has been previously described. [4,10-12] Stewart et al[11] reported that 26 (96%) of 27 patients receiving 1.5 mg/kg succinylcholine and 30 (94%) of 32 patients receiving 0.5 mg/kg had acceptable intubating conditions. However, in patients with a full stomach or in those with raised intracranial pressure, excellent intubating conditions are warranted. In our study, the administration of 0.8 and 0.6 mg/kg succinylcholine was associated with 100% and 95.7% incidence of excellent tracheal intubating conditions. In contrast Stewart et al reported that after induction of anaesthesia with 5 mg/kg thiopental, 23 (85%) of 27 patients receiving 1.5 mg/kg succinylcholine and 18 (56%) of 32 patients receiving 0.5 mg/kg succinylcholine had excellent intubating conditions at 60 s. Naguib et al[12] also found the incidence of excellent intubating conditions following induction with 2 [micro]g/kg fentanyl and 2 mg/kg propofol to be 0.0%, 43.3%, 60.0%, 63.3%, 80.0% and 86.7% of patients after 0.0, 0.3, 0.5, 0.8, 1.5 and 2.0 mg/kg succinylcholine, respectively. Our results indicate that apnoea time and time for resumption of regular spontaneous breathing (End-tidal C[O.sub.2] waveform) were dose-dependent. In all the three groups, start of regular spontaneous breathing occurred approximately 1 min after the detection of the first diaphragmatic movement. There was a statistically and clinically significant difference in apnoea time between 0.6 mg/kg and 1 mg/kg dose of succinylcholine (4.3 [+ or -] 0.9 min versus 8.2 [+ or -] 3.4 min, respectively). Return of regular spontaneous breathing occurred significantly earlier when the 0.6 mg/kg dose of succinylcholine was used compared with the 1 mg/kg (5.5 [+ or -] 1.1 min and 8.9 [+ or -] 3.5 min, respectively) dose. Although, initial spontaneous and regular breathing may not reflect complete functional recovery, this may still prevent haemoglobin desaturation that would ensue if the patient remained apnoeic. Thus, critical haemoglobin desaturation may not occur with the use of 0.6 mg/kg dose, especially in healthy adults. Because we did not allow our patients to desaturate, we cannot comment on the effect of these doses in a "Cannot Ventilate, Cannot Intubate" situation. However, Naguib et al [13] found that compared with the traditional intubating dose of 0.8 mg/kg succinylcholine, a reduction in succinylcholine dose to 0.56 mg/kg was associated with a 20% absolute decrease and a 50% relative decrease in the incidence of haemoglobin desaturation (Sp[O.sub.2] < 90%) in ASA physical status I patients anaesthetised with 2 [micro]g/kg fentanyl and 2 mg/kg succinylcholine.

Our results with regard to duration of apnoea are in contradistinction with that reported by others. El-Orbamy et al [14] noted that the mean time ([+ or -]SD) to spontaneous diaphragmatic movements after 0.6 mg/kg and 0.8 mg/kg succinylcholine were 3.41 [+ or -] 0.6 and 5.3 [+ or -] 8.0 min, respectively (P < 0.05). Hayes et al [6] reported that the recovery of diaphragmatic movements occurred 4.7 (SD [+ or -] 1.5-2.0) min after the administration of 1 mg/kg succinylcholine in patients with 1 [micro]g/kg fentanyl and 3 - 7 mg/kg thiopentone. Similarly, in volunteers who received 5 mg/kg thiopentone and 1 mg/kg succinylcholine, Heier et al [5] noted diaphragmatic activity of 5.2 ([+ or -]1.5 - 2.0) min after succinylcholine and Stewart et al [11] reported a 3.8 min apnoea time after 0.5 mg/kg.

An interesting finding of our study is the striking dissimilarity in the intubating conditions (better) obtained and the duration of apnoea (longer) observed following administration of three doses of succinylcholine compared with that reported previously in the literature. We are unable to explain this. Geographic location and ethnic background influence the potency and duration of action of drugs. Previous studies have shown that the response to muscle relaxants differs between geographical areas. Katz et al [15] reported that the neuromuscular blocking effect of succinylcholine (1 mg/kg) in adults was shorter in London (9.1 [+ or -] 2.9 min) than in New York (14.6 [+ or -] 3.6 min). Houghton et al [16] reported that the recovery of spontaneous ventilation after succinylcholine was 35% slower in Asian patients than in European patients. Hosseini et al [17] showed that Irish subjects (7.82 [+ or -] 0.14 U/mL) had more serum cholinesterase activity than Iranian subjects (4.22 [+ or -] 0.90 U/mL). These inter-racial differences in drug response could be due to differences in drug kinetics or sensitivity. [17] Thus, ethnic and geographic differences could possibly explain the differences found in our results in the Indian population.

Our study has several limitations. First, no control group was studied. The quality of intubating conditions without NMBAs is less predictable and the incidence of failed tracheal intubations is higher. We felt that intubation without NMBA is unlikely to be used in a rapid sequence induction scenario. Second, we did not study the onset and recovery times of different doses of succinylcholine by neuromuscular monitoring. In studies assessing the neuromuscular effects, succinylcholine is administered after calibration of the response to stimuli after induction of anaesthesia, and the results of intubating conditions so obtained cannot be applied to the clinical situation of rapid sequence induction. Evaluation of neuromuscular block at the laryngeal, diaphragm and masseter muscles [4] is done by monitoring adductor pollicis, but it was not useful as the diaphragm recovers faster than hand muscles after succinylcholine. [2] Pansard et al [18] demonstrated that diaphragm recovery occurs 2 min earlier than adductor pollicis recovery at all levels of twitch height recovery. Third, our results were obtained in young, healthy and normal weight patients. Increasing age, obesity and preexisting lung disease would make patients more vulnerable to desaturation. There are clinical situations in which "acceptable" conditions for tracheal intubation may not be ideal, e.g. a patient with increased intracranial pressure and a full stomach. In such patients, decreasing the dose of succinylcholine to less than 1 mg/kg might increase morbidity.

Our findings have clinical relevance in patients with unanticipated difficult airway. The faster return to spontaneous ventilation with 0.6 mg/kg dose increases the margin of safety in the event of a "Cannot Intubate, Cannot Ventilate" situation compared with 0.8 mg/kg dose.

CONCLUSION

To conclude, a reduction in succinylcholine dose to 0.6 mg/kg provided equally acceptable intubating conditions at 60 s compared with the use of 1 mg/kg succinylcholine during rapid sequence induction of anaesthesia with the advantage of a shorter apnoea time and time for regular spontaneous breathing.

REFERENCES

[1] Savarese JJ, Caldwell JE, Lien CA, et al. Pharmacology of muscle relaxants and their antagonists. In: Miller RD, edr. Anesthesia. 3rd edn. New York: Churchill Livingstone 2000: p. 412-90.

[2] Smith CE, Donati F, Bevan DR. Dose-response curves for succinylcholine: single versus cumulative techniques. Anesthesiology 1988;69(3):338-42.

[3] Kopman AF, Klewicka MM, Neuman GG. An alternate method for estimating the dose-response relationships of neuromuscular blocking drugs. Anesth Analg 2000;90(5):1191-7.

[4] Naguib M, Samarkandi A, Riad W, et al. Optimal dose of succinylcholine revisited. Anesthesiology 2003;99(5):1045-9.

[5] Heier T, Feiner JR, Lin J, et al. Hemoglobin desaturation after succinylcholine-induced apnea: a study of the recovery of spontaneous ventilation in healthy volunteers. Anesthesiology 2001;94(5):754-9.

[6] Hayes AH, Breslin DS, Mirakhur RK, et al. Frequency of haemoglobin desaturation with the use of succinylcholine during rapid sequence induction of anaesthesia. Acta Anaesthesiol Scand 2001;45(6):746-9.

[7] Benumof JL, Dagg R, Benumof R. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology 1997;87(4):979-82.

[8] Cormack RS, Lehane J. Difficult tracheal intubation in obstetrics. Anaesthesia 1984;39(11):1105-11.

[9] Viby-Mogensen J, Engbaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996;40(1):59-74.

[10] Nimmo SM, McCann N, Broome IJ, et al. Effectiveness and sequelae of very low-dose suxamethonium for nasal intubation. Br J Anaesth 1995;74(1):31-4.

[11] Stewart KG, Hopkins PM, Dean SG. Comparison of high and low doses of suxamethonium. Anaesthesia 1991;46(10):833-6.

[12] Naguib M, Samarkandi AH, El-Din ME, et al. The dose of succinylcholine required for excellent endotracheal intubating conditions. Anesth Analg 2006;102(1):151-5.

[13] Naguib M, Samarkandi AH, Abdullah K, et al. Succinylcholine dosage and apnea-induced hemoglobin desaturation in patients. Anesthesiology 2005;102(1):35-40.

[14] El-Orbamy MI, Joseph NJ, Salem MR, et al. The neuromuscular effects and tracheal intubation conditions after small doses of succinylcholine. Anesth Analg 2004;98(6):1680-5.

[15] Katz RL, Norman J, Seed RF, et al. A comparison of the effects of suxamethonium and tubocurarine in patients in London and New York. Br J Anaesth 1969;41(12):1041-7.

[16] Houghton IT, Aun CS, Gin T, et al. Suxamethonium myalgia: an ethnic comparison with and without pancuronium pre-treatment. Anaesthesia 1993;48(5):377-81.

[17] Hosseini J, Firuzian F, Feely J. Ethnic differences in the frequency distribution of serum cholinesterase activity. Ir J Med Sci 1997;166(1):10-2.

[18] Pansard JL, Chauvin M, Lebrault C, et al. Effect of an intubating dose of succinylcholine atracurium on the diaphragm and the adductor pollicis muscle in humans. Anesthesiology 1987;67(3):326-30.

Girish K. N (1), Rajashekar S (2)

(1) Associate Professor, Department of Anaesthesiology, BGS Global Institute of Medical Sciences, Kengeri, Bengaluru, Karnataka.

(2) Registrar, Department of Anaesthesiology, BGS Global Institute of Medical Sciences, Kengeri, Bengaluru, Karnataka.

'Financial or Other Competing Interest': None.

Submission 01-06-2018, Peer Review 01-07-2018, Acceptance 07-07-2018, Published 16-07-2018.

Corresponding Author: Dr. Girish K. N, #689, 16th Cross, 5th Block, HMT Layout, Vidyaranya Pura, Bangalore-560097, Karnataka, India.

E-mail: drgirishkn@yahoo.com

DOI: 10.14260/jem ds/2018/746
Table 1. Assessment of Intubating Conditions

                       Intubating Conditions
Variables              Acceptable                  Not Acceptable
                       Excellent    Good           Poor

Laryngoscopy           Easy         Fair           Difficult
Vocal cords
Position               Abducted     Intermediate   Closed
Movement               None         Moving         Closing
Coughing (>10 s)       None         Diaphragm      Sustained
Movement of limbs      None         Slight         Vigorous

Table 2. Patient Data

                       Group 0.4 (n=21)       Group 0.6 (n=23)

Age (yrs.)             33.4 [+ or -] 9.5      34.8 [+ or -] 13.2
Gender (M:F)           09:12                  07:16
Weight (kg)            53.2 [+ or -] 7.7      52.8 [+ or -] 7.2
Height (cm)            158.0 [+ or -] 5.3    156.7 [+ or -] 6.0

Mallampati class

Class 1                20(95.2)               19(82.6)
Class 2                1(4.8)                 4(17.4)

Cormack

Laryngoscopic view
Grade 1                21(100)                23(100)
Grade 2                0(0)                   0(0)

Duration of            9.8 [+ or -] 1.9       10.1 [+ or -] 2.1
Laryngoscopy(s)

                       Group 0.8 (n=20)       P value

Age (yrs.)             34.9 [+ or -] 10.6
Gender (M:F)           03:17
Weight (kg)            52.6 [+ or -] 11.6
Height (cm)            155.6 [+ or -] 7.9

Mallampati class

Class 1                17(85)                 0.18
Class 2                3(15)

Cormack

Laryngoscopic view
Grade 1                20(100)
Grade 2                0(0)

Duration of            11.2 [+ or -] 2.5      0.1
Laryngoscopy(s)

Table 3. Intubating Conditions and Requirement for
Rocuronium

Intubating             Group 0.4    Group 0.6      Group 0.8   P value
Conditions             (n=21)       (n=23)         (n=20)

Excellent              11(52.4)     22(95.7)       20(100)       0

Good                   3(14.3)      1(4.3)         0(0)

Poor                   7(33.3)      0(0)           0(0)

Overall intubating
conditions

Clinically             14(66.7)     23(100)        20(100)       0
acceptable

Clinically             7(33.3)      0(0)           0(0)
unacceptable

Rocuronium             0(0)         0(0)           0(0)
requirement

Table 4. Details of Intubating Conditions

                       Group 0.4   Group 0.6   Group 0.8    P value
                        (n=21)     (n=23)       (n=20)

Laryngoscopy (easy/    21/0/0      22/1/0       20/1/0      0.404
fair/difficult)

Vocal cords position   21/0/0      23/0/0       20/0/0     -(abducted/
intermediate/closed

Vocal cords            21/0/0      23/0/0       20/0/0     -movements
(none/
moving/closing)

Coughing (none/        11/6/4      14/8/1       20/0/0       0.004
diaphragm/
 sustained > 10s

Movement of the        14/2/5      19/4/0       19/1/0       0.012
limbs (none/slight/
vigorous)

Table 5. Apnoea Time and Time for Resumption of Regular
Spontaneous Breathing

                        Group 0.4 (n=21)       Group 0.6 (n=23)

Apnoea time (min)       3.8 [+ or -] 1.1      4.3 [+ or -] 0.9

Time for regular
spontaneous breathing   5.3 [+ or -] 1.2      5.5 [+ or -] 1.1
(min)

                        Group 0.8 (n=20)       P value

Apnoea time (min)       8.2 [+ or -] 3.4      0.00

Time for regular
spontaneous breathing   8.9 [+ or -] 3.5      0.00
(min)

Table 6. Heart Rate response to Induction and Intubation

                  Heart Rate (Beat/Min)
Time Point        Group 0.4 (n=21)     Group 0.6 (n=23)

Pre-induction     75 [+ or -] 13      80 [+ or -] 11
Post-induction    87 [+ or -] 14      83 [+ or -] 12
p/i 1 min         98 [+ or -] 18      97  [+ or -] 16
p/i 2 min         95 [+ or -] 18      92 [+ or -] 15
p/i 3 min         84 [+ or -] 11      87 [+ or -] 15
p/i 4 min         82 [+ or -] 10      85 [+ or -] 15
p/i 5 min         79 [+ or -] 10      81 [+ or -] 13

Time Point        Group 0.8 (n=20)     P value

Pre-induction     84 [+ or -] 9       0.072
Post-induction    93 [+ or -] 19      0.078
p/i 1 min         94  [+ or -] 14     0.8
p/i 2 min         91 [+ or -] 14      0.663
p/i 3 min         85 [+ or -] 13      0.724
p/i 4 min         81 [+ or -] 15      0.689
p/i 5 min         79  [+ or -] 13     0.738

Table 7. Mean Arterial Pressure response to Induction and
Intubation

                  Mean Arterial Blood Pressure (mmHg)
Time Point        Group 0.4            Group 0.6
                  (n=21)               (n=23)

Pre-induction     89 [+ or -] 6       92 [+ or -] 11
Post-induction    77 [+ or -] 12      77 [+ or -] 12
p/i 1 min         86 [+ or -] 12      90 [+ or -] 12
p/i 2 min         88 [+ or -] 13      87 [+ or -] 11
p/i 3 min         82 [+ or -] 10      83 [+ or -] 12
p/i 4 min         78 [+ or -] 8       80 [+ or -] 11
p/i 5 min         76 [+ or -] 8       79 [+ or -] 10

Time Point        Group 0.8            P
                  (n=20)               value

Pre-induction     93 [+ or -] 12      0.421
Post-induction    83 [+ or -] 15      0.21
p/i 1 min         83 [+ or -] 15      0.23
p/i 2 min         84 [+ or -] 14      0.621
p/i 3 min         79 [+ or -] 14      0.608
p/i 4 min         80 [+ or -] 13      0.656
p/i 5 min         78 [+ or -] 12      0.718
COPYRIGHT 2018 Akshantala Enterprises Private Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Original Research Article
Author:N, Girish K.; S, Rajashekar
Publication:Journal of Evolution of Medical and Dental Sciences
Article Type:Report
Date:Jul 16, 2018
Words:4148
Previous Article:A STUDY ON TONSIL CORE CULTURE IN CHRONIC AND RECURRENT TONSILLITIS.
Next Article:BODY MASS INDEX AND HEEL PAIN-A HOSPITAL-BASED STUDY.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |